Hostname: page-component-745bb68f8f-l4dxg Total loading time: 0 Render date: 2025-02-06T01:09:33.178Z Has data issue: false hasContentIssue false
  • English
  • Français

Diabetes mellitus, cardiovascular disease and hormone replacement therapy

Published online by Cambridge University Press:  23 October 2000

M Perera  and
MA Lumsden
M Perera
Affiliation:
Department of Obstetrics and Gynaecology, University of Glasgow, UK
MA Lumsden
Affiliation:
Department of Obstetrics and Gynaecology, University of Glasgow, UK
Get access Rights & Permissions [Opens in a new window]

Abstract

Diabetes mellitus is the most common chronic disease in the industrialized world. In North America and Europe the prevalence in adults is 7–8% and it is estimated that there are more than 100 million cases worldwide. With the increasing prevalence of non-insulin-dependent diabetes mellitus (NIDDM) this figure continues to rise. The World Health Organization predicts that the number of patients with diabetes will rise from 130 million to over 300 million over the next 25 years. Diabetes affects 1 in 30 people living in England and Wales and accounts for more than £2 billion of hospital costs annually. The number of diabetic patients in the UK is predicted to double to 3 million by the year 2010.

Type
Research Article
Information
Reproductive Medicine Review , Volume 8 , Issue 2 , July 2000 , pp. 153 - 172
Copyright
© 2000 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)